Contract Research Organization Announces Site Identification Patient Recruitment Solution for the Pharmaceutical Industry
Locating Investigational Sites Has Never Been Easy.
COSTA MESA, Calif., March 20, 2014 /PRNewswire-iReach/ — WCCT Global, a full service CRO specializing in early and late phase clinical research announced today the implementation of a cutting edge technology that allows WCCT Global to assist sponsors in identifying clinical investigational sites (CIS) that would be the best fit for their upcoming clinical trial anywhere in the United States. Clinical Investigational Sites are identified based on verified patient data sourced from many strategic partnerships with many healthcare providers and healthcare data sources. This CIS selection strategy provides sponsors access to multiple medical data sources and the ability to identify large clusters of patients being treated for the target indication. The ability to identify patients for a study allows sponsors to only initiate investigational sites where there are high concentrations of eligible patients and maximizes patient recruitment and utilization of CIS resources. Overall, WCCT Global’s system enables sponsors to locate patients through strategic healthcare provider partnerships and by searching by ICD-9 codes, pharmacy prescriber data, and multiple other data sources in order to provide the most suitable patient locations and clinical investigational sites available. This CIS strategy provides enormous time savings for CIS identification and ultimately clinical trial execution. This technology is part of WCCT Global’s full service patient recruitment platform called “In-Site“.
Lee Barsky, VP, Global Clinical Development, stated, “This technology is a homerun for sponsors looking for specific patient groups taking specific medications and potentially eligible for participation in early or late phase clinical trials. Partnering with sponsors to locate the best performing sites for their study is truly a unique service offering from a full service CRO then add in the fact that we are also analyzing the data from a CRO that owns sites – Now we are selecting sites from real time data which allows for only strategic selections, not guesses- To me this is truly “”In-Site” full”.
More about WCCT Global:
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you would like to request information about how WCCT Global can assist your organization with site selection, please CLICK HERE
Media Contact: Matt Miller, WCCT Global, 714.668.1500 ext.2029, Matt.Miller@wcct.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WCCT Global